BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Celsion Corporation 

997 Lenox Drive
Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-896-9100 Fax: 609-896-2200


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Medical Device






 Company News
Celsion Corporation (CLSN) Reports Third Quarter 2014 Financial Results 11/11/2014 8:33:22 AM
Celsion Corporation (CLSN) Receives VHP Approval To Initiate OPTIMA Study In Europe 11/5/2014 7:29:42 AM
Celsion Corporation (CLSN) To Hold Third Quarter 2014 Financial Results Conference Call On Tuesday, November 11, 2014 11/4/2014 9:03:51 AM
Celsion Corporation (CLSN) Presents Preclinical Data For Its TheraSilence™ Platform At The miRNA World Conference Workshop On miRNA Delivery 10/29/2014 8:09:48 AM
Celsion Corporation (CLSN) Announces Appointment Of Michael H. Tardugno To Executive Chairman Of The Board Of Directors 10/8/2014 8:21:48 AM
Celsion Corporation (CLSN) Announces The Unexpected Passing Of Max E. Link, Ph.D., Chairman Of The Board 10/8/2014 8:19:01 AM
Celsion Corporation (CLSN) Announces Highlights From Three Presentations Given At The International Liver Cancer Association 2014 Annual Conference 9/8/2014 9:24:34 AM
Celsion Corporation (CLSN) Reports Consolidated Duke University And Celsion's DIGNITY Study Clinical Data On Thermodox® In Recurrent Chest Wall Breast Cancer Published In The International Journal Of Hyperthermia 9/5/2014 10:48:50 AM
Celsion Corporation (CLSN) Announces Enrollment Of First Patient In Global Phase 3 OPTIMA Study Of Thermodox® In Primary Liver Cancer 9/3/2014 11:19:12 AM
Celsion Corporation (CLSN) To Present At Rodman & Renshaw 16th Annual Healthcare Conference 8/28/2014 1:31:36 PM
12345678910...